Stocks and Investing Stocks and Investing
Thu, May 11, 2023

Geulah Livshits Maintained (ACHL) at Strong Buy with Decreased Target to $11 on, May 11th, 2023


Published on 2024-10-28 03:40:40 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Achilles Therapeutics plc" (ACHL) at Strong Buy with Decreased Target from $12 to $11 on, May 11th, 2023.

Geulah, nor any peers, have made any analyst calls on ACHL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources